vs

Side-by-side financial comparison of Brookfield Asset Management Ltd. (BAM) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× Brookfield Asset Management Ltd.). Brookfield Asset Management Ltd. runs the higher net margin — 56.7% vs 21.2%, a 35.5% gap on every dollar of revenue.

Brookfield Asset Management Ltd. is a Canadian-American alternative asset manager. The company was founded in December 2022 as a spin-off of the asset management operations of Brookfield Corporation, and manages investments across real estate, infrastructure, renewable energy, private equity, and credit markets globally.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

BAM vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.2× larger
DXCM
$1.3B
$1.1B
BAM
Higher net margin
BAM
BAM
35.5% more per $
BAM
56.7%
21.2%
DXCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BAM
BAM
DXCM
DXCM
Revenue
$1.1B
$1.3B
Net Profit
$615.0M
$267.3M
Gross Margin
62.9%
Operating Margin
84.2%
25.6%
Net Margin
56.7%
21.2%
Revenue YoY
21.6%
Net Profit YoY
153.6%
EPS (diluted)
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAM
BAM
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$1.1B
$1.3B
Q3 25
$974.0M
$1.2B
Q2 25
$931.0M
$1.2B
Q1 25
$954.0M
$1.0B
Q4 24
$1.1B
Q3 24
$873.0M
$994.2M
Q2 24
$821.0M
$1.0B
Net Profit
BAM
BAM
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$615.0M
$267.3M
Q3 25
$692.0M
$283.8M
Q2 25
$584.0M
$179.8M
Q1 25
$507.0M
$105.4M
Q4 24
$151.7M
Q3 24
$537.0M
$134.6M
Q2 24
$124.0M
$143.5M
Gross Margin
BAM
BAM
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
BAM
BAM
DXCM
DXCM
Q1 26
25.6%
Q4 25
84.2%
25.6%
Q3 25
79.1%
20.1%
Q2 25
70.8%
18.4%
Q1 25
61.0%
12.9%
Q4 24
17.0%
Q3 24
72.5%
15.3%
Q2 24
80.4%
15.7%
Net Margin
BAM
BAM
DXCM
DXCM
Q1 26
21.2%
Q4 25
56.7%
21.2%
Q3 25
71.0%
23.5%
Q2 25
62.7%
15.5%
Q1 25
53.1%
10.2%
Q4 24
13.6%
Q3 24
61.5%
13.5%
Q2 24
15.1%
14.3%
EPS (diluted)
BAM
BAM
DXCM
DXCM
Q1 26
$0.67
Q4 25
$0.67
Q3 25
$0.70
Q2 25
$0.45
Q1 25
$0.27
Q4 24
$0.37
Q3 24
$0.34
Q2 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAM
BAM
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$1.6B
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.9B
$2.7B
Total Assets
$17.0B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAM
BAM
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$1.6B
$917.7M
Q3 25
$1.1B
$1.8B
Q2 25
$480.0M
$1.2B
Q1 25
$332.0M
$904.9M
Q4 24
$606.1M
Q3 24
$621.2M
Q2 24
$10.0M
$939.2M
Stockholders' Equity
BAM
BAM
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$8.9B
$2.7B
Q3 25
$8.5B
$2.7B
Q2 25
$8.5B
$2.6B
Q1 25
$8.5B
$2.3B
Q4 24
$2.1B
Q3 24
$9.0B
$2.0B
Q2 24
$3.2B
$2.4B
Total Assets
BAM
BAM
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$17.0B
$6.3B
Q3 25
$16.5B
$7.5B
Q2 25
$16.1B
$7.3B
Q1 25
$15.0B
$6.8B
Q4 24
$6.5B
Q3 24
$6.4B
Q2 24
$4.2B
$6.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAM
BAM
DXCM
DXCM
Operating Cash FlowLast quarter
$562.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.91×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAM
BAM
DXCM
DXCM
Q1 26
Q4 25
$562.0M
$294.0M
Q3 25
$745.0M
$659.9M
Q2 25
$529.0M
$303.0M
Q1 25
$265.0M
$183.8M
Q4 24
$301.4M
Q3 24
$567.0M
$199.5M
Q2 24
$159.0M
$279.4M
Free Cash Flow
BAM
BAM
DXCM
DXCM
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
BAM
BAM
DXCM
DXCM
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
BAM
BAM
DXCM
DXCM
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
BAM
BAM
DXCM
DXCM
Q1 26
Q4 25
0.91×
1.10×
Q3 25
1.08×
2.33×
Q2 25
0.91×
1.69×
Q1 25
0.52×
1.74×
Q4 24
1.99×
Q3 24
1.06×
1.48×
Q2 24
1.28×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAM
BAM

Incentive Fees$452.0M42%
Infrastruture$332.0M31%
Private Equity$174.0M16%
Renewable Power And Transition$66.0M6%
Other$47.0M4%
Management And Advisory Fees$14.0M1%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons